INTERPACE BIOSCIENCES, INC.: depreciation, depletion and amortization

What this measure means

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Exact concept: us-gaap:DepreciationDepletionAndAmortization. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2010-01-01 to 2025-12-31. The SEC response was captured on 2026-09-20.

Selected filing history

Related financial histories

• INTERPACE BIOSCIENCES, INC.: total assets
• INTERPACE BIOSCIENCES, INC.: total liabilities
• INTERPACE BIOSCIENCES, INC.: stockholders equity
• INTERPACE BIOSCIENCES, INC.: cash and cash equivalents
• INTERPACE BIOSCIENCES, INC.: net income or loss
• INTERPACE BIOSCIENCES, INC.: operating cash flow
• INTERPACE BIOSCIENCES, INC.: capital expenditure payments
• INTERPACE BIOSCIENCES, INC.: revenue
• INTERPACE BIOSCIENCES, INC.: contract revenue excluding tax
• INTERPACE BIOSCIENCES, INC.: financing cash flow
• INTERPACE BIOSCIENCES, INC.: investing cash flow
• INTERPACE BIOSCIENCES, INC.: retained earnings or deficit
• INTERPACE BIOSCIENCES, INC.: basic weighted-average shares
• INTERPACE BIOSCIENCES, INC.: diluted weighted-average shares
• INTERPACE BIOSCIENCES, INC.: basic earnings per share
• INTERPACE BIOSCIENCES, INC.: diluted earnings per share
• INTERPACE BIOSCIENCES, INC.: income tax expense or benefit
• INTERPACE BIOSCIENCES, INC.: net property, plant and equipment
• INTERPACE BIOSCIENCES, INC.: share-based compensation expense
• INTERPACE BIOSCIENCES, INC.: operating income or loss
• INTERPACE BIOSCIENCES, INC.: current assets
• INTERPACE BIOSCIENCES, INC.: interest expense
• INTERPACE BIOSCIENCES, INC.: current liabilities
• INTERPACE BIOSCIENCES, INC.: current accounts payable
• INTERPACE BIOSCIENCES, INC.: goodwill carrying amount
• INTERPACE BIOSCIENCES, INC.: net finite-lived intangible assets
• INTERPACE BIOSCIENCES, INC.: net current accounts receivable
• INTERPACE BIOSCIENCES, INC.: common-stock repurchase payments
• INTERPACE BIOSCIENCES, INC.: operating expenses
• INTERPACE BIOSCIENCES, INC.: net inventory
• INTERPACE BIOSCIENCES, INC.: gross profit
• INTERPACE BIOSCIENCES, INC.: cost of revenue
• INTERPACE BIOSCIENCES, INC.: research and development expense
• INTERPACE BIOSCIENCES, INC.: common shares outstanding
• INTERPACE BIOSCIENCES, INC.: cash including restricted cash
• INTERPACE BIOSCIENCES, INC.: additional paid-in capital
• INTERPACE BIOSCIENCES, INC.: accumulated other comprehensive income or loss
• INTERPACE BIOSCIENCES, INC.: total equity including noncontrolling interests
• INTERPACE BIOSCIENCES, INC.: operating lease right-of-use asset
• INTERPACE BIOSCIENCES, INC.: operating lease liability
• INTERPACE BIOSCIENCES, INC.: gross property, plant and equipment
• INTERPACE BIOSCIENCES, INC.: accumulated depreciation on property, plant and equipment
• INTERPACE BIOSCIENCES, INC.: net intangible assets excluding goodwill
• INTERPACE BIOSCIENCES, INC.: other noncurrent assets
• INTERPACE BIOSCIENCES, INC.: other noncurrent liabilities
• INTERPACE BIOSCIENCES, INC.: accrued current liabilities
• INTERPACE BIOSCIENCES, INC.: net deferred tax assets
• INTERPACE BIOSCIENCES, INC.: pre-tax income or loss from continuing operations
• INTERPACE BIOSCIENCES, INC.: comprehensive income or loss
• INTERPACE BIOSCIENCES, INC.: net income available to common stockholders
• INTERPACE BIOSCIENCES, INC.: general and administrative expense
• INTERPACE BIOSCIENCES, INC.: depreciation expense
• INTERPACE BIOSCIENCES, INC.: amortization of intangible assets
• INTERPACE BIOSCIENCES, INC.: other nonoperating income or expense
• INTERPACE BIOSCIENCES, INC.: current income tax expense or benefit
• INTERPACE BIOSCIENCES, INC.: deferred income tax expense or benefit
• INTERPACE BIOSCIENCES, INC.: interest paid, net
• INTERPACE BIOSCIENCES, INC.: income taxes paid, net
• INTERPACE BIOSCIENCES, INC.: proceeds from issuing common stock
• INTERPACE BIOSCIENCES, INC.: operating lease payments
• INTERPACE BIOSCIENCES, INC.: change in accounts receivable
• INTERPACE BIOSCIENCES, INC.: change in accounts payable

Inspect the source

Entity

INTERPACE BIOSCIENCES, INC. / CIK 0001054102

Captured

2026-09-20T05:17:40.623Z

SEC response SHA-256

e9ff5500f02b0421b4291c86aa6f26c473e35b277fe04fed239c16a08258dae5

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001054102.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))